Evidence map›Paper›PMID 38275815›Full record

ArticleCells2024

Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood-Brain Barrier.

Yunfei Li, David B Shteyman, Zeina Hachem, Afaf A Ulay, Jie Fan, Bingmei M Fu

Open access · goldAbstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Tumor Metastasis in the Microcirculation.Advances in experimental medicine and biology · 2026
    Review
  3. Endothelial Surface Glycocalyx in Vascular Functions and Diseases.Advances in experimental medicine and biology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. The Glycocalyx: The Importance of Sugar Coating the Blood-Brain Barrier.International journal of molecular sciences · 2024
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yunfei LiDepartment of Biomedical Engineering, The City College of the City University of New York, New York, NY 10031, USA.
David B ShteymanDepartment of Biomedical Engineering, The City College of the City University of New York, New York, NY 10031, USA.
Zeina HachemDepartment of Natural Sciences, CASL, University of Michigan-Dearborn, Dearborn, MI 48128, USA.
Afaf A UlayDepartment of Biomedical Engineering, The City College of the City University of New York, New York, NY 10031, USA.
Jie FanDepartment of Natural Sciences, CASL, University of Michigan-Dearborn, Dearborn, MI 48128, USA.ORCID 0000-0002-3196-5468
Bingmei M FuDepartment of Biomedical Engineering, The City College of the City University of New York, New York, NY 10031, USA.ORCID 0000-0001-9343-5895
City College of New York · USUniversity of Michigan–Dearborn · US

Funding

Research Center in Minority Institutions (RCMI) at City CollegeU54MD017979 · NIMHD · CITY COLLEGE OF NEW YORK · PI M. Felice Marina GHILARDI · 2024 to 2026
$15.9M
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screeningUH3TR002151 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEONG, KAM W · 2020 to 2022
$3.6M
The coupled vascular hypothesis for transcranial direct current stimulation (tDCS)R01NS101362 · NINDS · CITY COLLEGE OF NEW YORK · PI BIKSON, MAROM · 2017 to 2021
$1.7M
NCATS NIH HHS UH3 TR002151NIH HHS 1UG3UH3TR002151NIH HHS RO1NS101362NIMHD NIH HHS U54 MD017979NINDS NIH HHS R01 NS101362
6 · The paper itself

Abstract

The disruption of endothelial heparan sulfate (HS) is an early event in tumor cell metastasis across vascular barriers, and the reinforcement of endothelial HS reduces tumor cell adhesion to endothelium. Our recent study showed that while vascular endothelial growth factor (VEGF) greatly reduces HS at an in vitro blood-brain barrier (BBB) formed by human cerebral microvascular endothelial cells (hCMECs), it significantly enhances HS on a breast cancer cell, MDA-MB-231 (MB231). Here, we tested that this differential effect of VEGF on the HS favors MB231 adhesion and transmigration. We also tested if agents that enhance endothelial HS may affect the HS of MB231 and reduce its adhesion and transmigration. To test these hypotheses, we generated an in vitro BBB by culturing hCMECs on either a glass-bottom dish or a Transwell filter. We first quantified the HS of the BBB and MB231 after treatment with VEGF and endothelial HS-enhancing agents and then quantified the adhesion and transmigration of MB231 across the BBB after pretreatment with these agents. Our results demonstrated that the reduced/enhanced BBB HS and enhanced/reduced MB231 HS increase/decrease MB231 adhesion to and transmigration across the BBB. Our findings suggest a therapeutic intervention by targeting the HS-mediated breast cancer brain metastasis.

Indexed as

Blood-Brain BarrierBreast NeoplasmsCell AdhesionEndothelial CellsFemaleHumansVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsVascular Endothelial Growth Factor AVascular Endothelial Growth Factorsblood–brain barrierglycocalyxheparinase IIImatrix metalloproteinase (MMP) inhibitorMDA-MB-231orosomucoidsphingosine-1-phosphate (S1P)vascular endothelial growth factor (VEGF)

Identifiers

PMID38275815
PMCPMC10813861
OpenAlexW4391029977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.